SCHEMBL305505

SCHEMBL305505

O=C(O)c1cc(I)ccc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.63
TP53 P04637 1/20 0.63
TDP1 Q9NUW8 3/20 0.53
KDM4E B2RXH2 2/20 0.53
POLB P06746 2/20 0.53
NPC1 O15118 1/20 0.53
MAPT P10636 1/20 0.53
RAB9A P51151 1/20 0.53
LMNA P02545 1/20 0.52
PTPRC P08575 1/20 0.50
PTPN2 P17706 1/20 0.50
PTPN1 P18031 1/20 0.50
PTPRA P18433 1/20 0.50
PTPRB P23467 1/20 0.50
PTPRE P23469 1/20 0.50
PTPN6 P29350 1/20 0.50
CTSB P07858 1/20 0.49
TSHR P16473 4/20 0.47
CASP1 P29466 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31364369 1.00 ALDH1A1 (0.63) ALDH1A1TP53TDP1KDM4EPOLB
SCHEMBL27994220 0.98 ALDH1A1 (0.61) ALDH1A1TP53TDP1KDM4EPOLB
SCHEMBL1820547 0.83 TSHR (0.63) ALDH1A1TP53TDP1KDM4EPOLB
SCHEMBL1934879 0.83 ALDH1A1 (0.42) ALDH1A1TP53TDP1KDM4EPOLB
SCHEMBL1786179 0.81 ALDH1A1 (0.50) ALDH1A1TP53TDP1KDM4EPOLB
SCHEMBL21921083 0.81 ALDH1A1 (0.41) ALDH1A1TP53TDP1KDM4EPOLB
SCHEMBL522679 0.79 PTPN1 (0.55) ALDH1A1TDP1KDM4EPOLBMAPT
SCHEMBL1277864 0.77 PTPRC (0.53) ALDH1A1PTPRCPTPN2PTPN1PTPRA
SCHEMBL224469 0.77 ALDH1A1 (1.00) ALDH1A1TP53TDP1KDM4EPOLB
SCHEMBL2771204 0.77 ALDH1A1 (0.68) ALDH1A1TP53TDP1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 423 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025024882-A1 FLUORINATED ADAMANTYL P2X7 RECEPTOR ANTAGONISTS AND USES THEREOF THE UNIVERSITY OF SYDNEY (AU) 2025-02-06 WO claimed
CN-118184679-A Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material 中国石油天然气股份有限公司 2024-06-14 CN claimed
CN-118005503-A Method for synthesizing 2-chloro-5-iodobenzoic acid by catalyzing iodo through o-chlorobenzoic acid 宜春学院 2024-05-10 CN claimed
CN-117186035-A Synthesis process of englitz intermediate 安徽美诺华药物化学有限公司 2023-12-08 CN claimed
CN-115260174-A 5- (pyrazole-4-yl) -1,2, 4-oxadiazole substituted benzamide compounds and preparation method and application thereof 浙江工业大学 2022-11-01 CN claimed
CN-114213365-A Synthetic method of empagliflozin intermediate 山东鲁宁药业有限公司 2022-03-22 CN claimed
CN-113880701-A Antidiabetic drug intermediate and preparation method thereof 浙江司太立制药股份有限公司 2022-01-04 CN claimed
CN-111592533-B 1,2, 4-oxadiazole bipyridyl substituted benzamide compound and preparation method and application thereof 浙江工业大学 2021-08-24 CN claimed
CN-111410639-B Preparation method of empagliflozin intermediate impurity 天津法莫西医药科技有限公司 2021-02-26 CN claimed
CN-111592533-A 1,2, 4-oxadiazole bipyridyl substituted benzamide compound and preparation method and application thereof 浙江工业大学 2020-08-28 CN claimed
CN-111410639-A Preparation method of empagliflozin intermediate impurity 天津法莫西医药科技有限公司 2020-07-14 CN claimed
CN-106748721-B A kind of preparation method of the chloro- 5- iodo-benzoic acid of 2- 山东铂源药业有限公司 2019-06-21 CN claimed
CN-106748721-A A kind of preparation method of the iodo-benzoic acid of 2 chlorine 5 山东铂源药业有限公司 2017-05-31 CN claimed
CN-104193616-B The synthetic method of the chloro-5-iodo-benzoic acid of a kind of 2- JIANGSU DEFENG PHARMACEUTICAL CO., LTD. (CN) 2015-10-21 CN claimed
CN-104193616-A A synthetic method of 2-chloro-5-iodobenzoic acid LIAONING DEFENG PHARMACEUTICAL & CHEMICAL CO LTD 2014-12-10 CN claimed
CN-104086361-A Preparation method of 2-chloro-5-iodobenzoic acid NANTONG HUAFENG CHEMICAL CO 2014-10-08 CN claimed
EP-4653053-A1 PPARG INVERSE AGONISTS AND USES THEREOF Flare Therapeutics, Inc. (US) 2025-11-26 EP disclosed
EP-4426434-B1 PPARG INVERSE AGONISTS AND USES THEREOF FLARE THERAPEUTICS INC (US) 2025-08-20 EP disclosed
WO-2001023347-A1 NOVEL AROMATIC COMPOUNDS NOVO NORDISK A/S (DK) 2001-04-05 WO disclosed
WO-2000001692-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2000-01-13 WO disclosed